FDA reverses decision not to review Moderna’s new flu vaccine

The Food and Drug Administration has reversed its decision not to review a new flu vaccine from Moderna, the pharmaceutical company said Wednesday. Last week, the FDA sent a missive to Moderna refusing to review its new shot, saying its application did not contain adequate research – leaving the company’s president, Dr. Stephen Hoge, in “complete shock.” In an exclusive interview with The Post, Hoge said he was “completely surprised and honestly...